Archives
Benefit from rapid, rigorous peer review and open access publishing that puts your work in front of the right audience.
Submit Your Manuscript →Issue No: 1
Iclaprim is a novel bacterial dihydrofolate reductase inhibitor in Phase 3 clinical development for the treatment of acute bacterial skin and skin structure infections and hospital acquired bacterial pneumonia caused by Gram-positve bacteria...
Co-infection of HIV with Mycobacterium tuberculosis is a common event, particularly in developing countries. The emergence and spread of multidrug resistant tuberculosis (MDR-TB) is an increasing public problem in India. The drug-resistant M...
📚 Indexed & Abstracted In
Our journal is indexed in leading academic databases and search engines
